Drugmaker raises the price of an old chemo medicine tenfold amid persistent shortages - STAT

1 year ago 37

Amid sporadic shortages of a cause that is indispensable successful preparing patients for lifesaving, cancer-fighting treatments, 1 shaper has returned to the marketplace — but is selling its medicine for 10 to 20 times the prices offered by the lone different companies with disposable supplies.

Over the past week, Areva Pharmaceuticals began selling vials of fludarabine astatine a wholesale terms of $2,736, a overmuch steeper outgo than the $272 charged for the aforesaid dosage by Fresenius Kabi and the $109 terms tag from Teva Pharmaceuticals, according to information from IBM Micromedex, which gathers pricing information that is reported by manufacturers.

Unlock this nonfiction by subscribing to STAT+ and bask your archetypal 30 days free!

GET STARTED

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Create a show sanction to comment

This sanction volition look with your comment

Read Entire Article